Orexo AB logo

Orexo AB

kr 30.45 (-6.31%) Aug 17
P/E:
At Loss
P/B:
3.38
Market Cap:
kr 1.05B ($ 100.60M)
Enterprise V:
kr 1.12B ($ 107.96M)
Volume:
107.44K
Avg Vol (2M):
70.12K
Also Trade In:
Volume:
107.44K
Market Cap kr:
1.05B
Market Cap $:
100.60M
PE Ratio:
At Loss
Avg Vol (2-Month):
70.12K
Enterprise Value kr:
1.12B
Enterprise Value $:
107.96M
PB Ratio:
3.38
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
Orexo AB develops pharmaceuticals and digital therapies addressing unmet needs within the space of substance use disorders and mental health. The products are commercialized by Orexo in the USA or via partners worldwide. The main market is the American market for buprenorphine/naloxone products, where the company commercializes its product Zubsolv for treatment of opioid use disorder. The head office, where research and development is also performed, is situated in Uppsala, Sweden.
Name Current Vs Industry Vs History
Cash-To-Debt 0.86
Equity-to-Asset 0.24
Debt-to-Equity 1.76
Debt-to-EBITDA -5.15
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.19
Distress
Grey
Safe
Beneish M-Score -1.54
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 57.06
9-Day RSI 64.36
14-Day RSI 65.45
6-1 Month Momentum % 2.77
12-1 Month Momentum % -40.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.05
Quick Ratio 1.85
Cash Ratio 1.08
Days Inventory 358.06
Days Sales Outstanding 149.39
Days Payable 198.65

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 0.2

Financials (Next Earnings Date:2022-11-03)

OSTO:ORX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 597.1
EPS (TTM) (kr) -5.16
Beta 1.47
Volatility % 56.3
14-Day RSI 65.45
14-Day ATR (kr) 2.035299
20-Day SMA (kr) 26.3625
12-1 Month Momentum % -40.74
52-Week Range (kr) 16.96 - 39.96
Shares Outstanding (Mil) 34.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Orexo AB Filings

Document Form Filing Date
No Filing Data